BIAFW logo

bioAffinity Technologies, Inc. Warrant


BIAFW: bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.


Show BIAFW Financials

Consumer Interest
SEC Filings

Recent trades of BIAFW by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by BIAFW's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of BIAFW in WallStreetBets Daily Discussion


Recent insights relating to BIAFW

CNBC Recommendations

Recent picks made for BIAFW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BIAFW

Corporate Flights

Flights by private jets registered to BIAFW